Treatment Paradigms for Patients with Metastatic Non-Small Cell Lung Cancer, Squamous Lung Cancer: First, Second, and Third-Line

Por Al-Farsi, Abdulaziz, Ellis, Peter Michael
Publicado em 2014

Anti-angiogenic therapy in advanced non-small cell lung carcinoma (NSCLC): is there a role in subsequent lines of therapy?

Por Al Farsi, Abdulaziz, Ellis, Peter M.
Publicado no J Thorac Dis (2015)

Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk

Por Al-Moundhri, Mansour S, Al-Khanbashi, Manal, Al-Kindi, Mohammed, Al-Nabhani, Maryam, Burney, Ikram A, Al-Farsi, Abdulaziz, Al-Bahrani, Bassim
Publicado em 2010

Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab

Por Al-Shamsi, Humaid O., Al Farsi, Abdulaziz, Anjum, Mahraz, Shen, Hua, Zbuk, Kevin, Cook, Richard J., Linkins, Lori-Ann, Major, Pierre
Publicado no J Gastrointest Oncol (2015)